CIK: 0001019231 · Show all filings
Period: Q1 2023 (← Previous) (Next →)
Filing Date: May 22, 2023
Total Value ($000): $260 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| BBRE | JPM BETABLDRS MSCI US REIT | 2,654,694 | $220 | 84.5% | $91.03 | — | ETFS | 46641Q738 |
| — | ELLIOTT OPPORTUNITY II CORP | 2,000,000 | $20 | 7.9% | $10.01 | — | COM | G30092129 |
| TXN | TEXAS INSTRUMENTS INC | 32,000 | $6 | 2.3% | $57.24 | +181.9% | COM | 882508104 |
| IMTX | IMMATICS NV | 697,431 | $5 | 1.8% | $10.53 | -22.3% | COM | N44445109 |
| VT | VANGUARD TOT WORLD STK ETF | 29,585 | $3 | 1.0% | $80.77 | — | ETFS | 922042742 |
| — | HASHICORP INC | 85,603 | $3 | 1.0% | $10.20 | — | COM | 418100103 |
| BEAM | BEAM THERAPEUTICS INC | 59,839 | $2 | 0.7% | $39.47 | 0.0% | COM | 07373V105 |
| BOND | PIMCO ACTIVE BOND EXCHANGE-T | 15,502 | $1 | 0.6% | $107.83 | — | COM | 72201R775 |
| — | APOLLO ENDOSURGERY INC | 15,601 | $0 | 0.1% | $3.88 | — | COM | 03767D108 |
| — | CODIAK BIOSCIENCES INC | 847,108 | $0 | 0.1% | $15.08 | — | COM | 192010106 |
| LXRX | LEXICON PHARMACEUTICALS INC | 35,714 | $0 | 0.0% | $7.34 | -68.8% | COM | 528872302 |
| — | AEGLEA BIOTHERAPEUTICS INC | 245,678 | $0 | 0.0% | $6.41 | — | COM | 00773J103 |
| DE | DEERE & CO | 63 | $0 | 0.0% | $396.55 | +0.1% | COM | 244199105 |
| — | TFF PHARMACEUTICALS INC | 22,066 | $0 | 0.0% | $18.47 | — | COM | 87241J104 |
| HESM | HESS MIDSTREAM LP | 340 | $0 | 0.0% | $22.89 | 0.0% | LP - PUBLIC EQUITY | 428103105 |
| — | PLX PHARMA INC | 62,673 | $0 | 0.0% | $3.39 | — | COM | 72942A107 |
| BR | BROADRIDGE FINANCIAL SOLUTIONS | 45 | $0 | 0.0% | $136.28 | 0.0% | COM | 11133T103 |
| POR | PORTLAND GENERAL ELECTRIC CO | 118 | $0 | 0.0% | $20.00 | +108.9% | COM | 736508847 |
| PG | PROCTER & GAMBLE CO/THE | 18 | $0 | 0.0% | $133.20 | 0.0% | COM | 742718109 |